NCT01213303

Brief Summary

Cardiovascular diseases belong to the major causes of mortality in western populations, and atherosclerosis is the lesion responsible for clinical events, such as acute myocardial infarction and stroke. Atherosclerosis remains asymptomatic until a clinical event occurs, and in the pre-clinical stage it may be difficult to diagnose. As disease surrogate, a large number of risk factors for atherosclerosis are being recognized. Some of them are responsible for the epidemiologically very serious metabolic syndrome, which accounts for development of hyperlipidemia, obesity, diabetes or arterial hypertension. Health providers in continental diet-based countries suggest to embracing Mediterranean diet in order to contribute in reducing cardiovascular mortality. However, countries in the Mediterranean area are experiencing a shift in dietary habit towards continental diet with potential harmful change in mortality rates. Oxidative stress, including free radical-driven reactions and antioxidant status are considered important mediators to be considered in the diet-mediated effect on health. Important metabolic functions are also mediated by certain fatty acids. A comprehensive study of oxidative stress, including free radical-driven products and protective antioxidants, and fatty acids metabolism has never been reported in healthy subjects. In particular, high sensitive mass-spectrometry methods to study oxidative stress and fatty acids metabolism are rarely applied to epidemiological studies. The aim of the present grant project is therefore to assess in a large cross-sectional study the prevalence of oxidative stress markers, and fatty acids and to find any causal relation between these variables and metabolic syndrome. This population sample will be followed prospectively not only for time of the present grant project, but we would like to study metabolic variables with relation to the development of oxidative stress-mediated diseases, in particular those of cardiovascular system, on a longitudinal basis (prospective epidemiological study for at least 10 years). At same time we should be able to define the importance of individual markers of oxidative stress and fatty acids for early detection of these diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2009

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 30, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2010

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

December 11, 2015

Status Verified

December 1, 2015

Enrollment Period

6.6 years

First QC Date

September 30, 2010

Last Update Submit

December 10, 2015

Conditions

Keywords

cardiovascular riskmetabolic syndromefatty acidsoxysterolsantioxidantsoxidative stress

Outcome Measures

Primary Outcomes (1)

  • Fatty acids lipidomics and oxidative stress markers in healthy subjects

    Assessment of plasma reference values of the complete fatty acid profile, oxysterols and alpha- and gamma-tocopherol in healthy italian subjects

    21 months

Secondary Outcomes (2)

  • Prevalence of fatty acids levels, in a complete panel, and markers of oxidative stress in subjects with metabolic syndrome

    21 months

  • Ten-year follow-up

    ten years

Study Arms (1)

Blood donors

Evaluation of cardiovascular risk factors, oxidative stress and fatty acid metabolism in a cohort of blood donors

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of healthy blood donors

You may qualify if:

  • Consecutive enrollment of blood donors

You may not qualify if:

  • Subjects with known chronic disease, including cardiovascular disease, liver disease, kidney disease, neurodegenerative disease and cancer; autoimmune disease, endocrine system disease,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

AVIS

Latina, Latina, 04100, Italy

Location

Vascular Medicine Unit, Department of Medical Science and Biotechnology

Latina, Latina, 04100, Italy

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Collection of plasma and serum samples

MeSH Terms

Conditions

Cardiovascular DiseasesMetabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Luigi Iuliano, M.D., Ph.D.

    University of Roma La Sapienza

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

September 30, 2010

First Posted

October 1, 2010

Study Start

May 1, 2009

Primary Completion

December 1, 2015

Study Completion

December 1, 2021

Last Updated

December 11, 2015

Record last verified: 2015-12

Locations